Breast Cancer Stage II-III
1 clinical trials · Condition
◉ Watch Breast Cancer Stage II-III
| Record | Firm | Date |
|---|---|---|
| Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer (NCT01560663) | Miguel Martín Jiménez | 2012-01-01 |
Track Breast Cancer Stage II-III automatically
Every clearance here is in the API, with alerts when new ones post.